Supreme Court to hear abortion pill case after FDA loosens distribution rules

Dec 13, 2023 View Original Article
  • Bias Rating

    22% Somewhat Conservative

  • Reliability

    70% ReliableGood

  • Policy Leaning

    14% Somewhat Conservative

  • Politician Portrayal

    78% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

58% Positive

  •   Conservative
SentenceSentimentBias
"In November 2022, the Alliance for Hippocratic Medicine, the American Association of Pro-Life Obstetricians & Gynecologists, the Christian Medical & Dental Associations and four individual doctors filed a lawsuit seeking to overturn the FDA's 2000 approval of mifepristone."
Negative
-2% Liberal
"This Administration will continue to stand by FDA's independent approval and regulation of mifepristone as safe and effective, she said in a statement."
Negative
-8% Liberal
"While the Supreme Court granted the requests by the Biden administration to overturn lower court rulings against its relaxing of longstanding distribution regulations, the high court rejected the request of the pro-life organizations to weigh in on the legality of the FDA's 2000 approval of mifepristone."
Negative
-12% Liberal
Upgrade your account to obtain complete site access and more analytics below.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

49% : In November 2022, the Alliance for Hippocratic Medicine, the American Association of Pro-Life Obstetricians & Gynecologists, the Christian Medical & Dental Associations and four individual doctors filed a lawsuit seeking to overturn the FDA's 2000 approval of mifepristone.
46% : ""This Administration will continue to stand by FDA's independent approval and regulation of mifepristone as safe and effective," she said in a statement.
44% : While the Supreme Court granted the requests by the Biden administration to overturn lower court rulings against its relaxing of longstanding distribution regulations, the high court rejected the request of the pro-life organizations to weigh in on the legality of the FDA's 2000 approval of mifepristone.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link